Cough & Cold


Ectoin® Rhinitis Nasal Spray

Natural treatment and relief of rhinitis and rhinosinusitis

Claims

Nasal Spray for treatment and prevention of non-allergic rhinitis or rhinosinusitis symptoms.

  • Reduces inflammation of disturbed nasal mucosa and sinuses caused by rhinitis and rhinosinusitis (common cold).
  • Alleviates typical symptoms such as dry and wound nasal epithelium, sneezing, itching and crust formation.
  • Decongests the nose and sinuses naturally.
  • Supports the reduction in the use of decongestant nasal sprays.

Ingredients

Ectoin®, Sea Salt, Phosphate Buffer, Water.

Suitable for

Infants, children, adolescents and adults.

Dosage Forms

20 ml bottle with dosage pump

 Study Overview

Eichel et. al., 2013

  • Tested against German OTC bestseller: Ectoin® Rhinitis Nasal Spray is as effective as Sinupret® forte.
  • Significant reduction of primary symptoms during acute rhinosinusitis

Status (EU): Medical Device Class Is (under approval)


Ectoin® Nasal Douche

Gentle cleansing and intense moisturization of the nasal mucosa

Claims

Nasal douche for prevention and treatment of rhinitis and rhinosinusitis symptoms.

  • Reduces inflammation of disturbed mucosa in the nose.
  • Alleviates symptoms such as dry and sore nasal mucosa, sneezing, itching, congestion, and crust formation.
  • Reduces harmful influences of allergens and airborne particles.
  • Supports the regeneration process of irritated nasal mucosa.
  • Gently cleans nasal cavities.
  • Provides essential moisture and prevents dehydration.
  • Helps to decongest the nasal mucosa naturally.

Ingredients

Ectoin®, Sea Water, Purified Water.

Suitable for

Infants, children, adolescents and adults.

Dosage Forms

50 ml, 100 ml or 125 ml solution in a bag on valve system

 Study Overview

Comparative study to evaluate the impact of Ectoin Nasal Douche on Xylometazoline therapy: Significantly superior improvement of nasal obstruction, secretion, facial pain, loss of smell and taste and dryness when using Ectoin Nasal Douche together with Xylometazoline nasal spray.
 

Status (EU): Medical Device Class IIa (under approval)


Ectoin® Mouth & Throat Spray

Effective treatment of sore throat, cough and hoarseness and pain on swallowing

Claims

Mouth and Throat Spray for treatment of dry and irritated epithelia in mouth and throat.

  • Supports reduction of inflammations of the mucous membranes in mouth and throat.
  • Reduces symptoms, such as sore throat, hoarseness, cough, and pain on swallowing.
  • Hydrates dry and irritated epithelia and supports regeneration by stabilization of mucosal barrier structure.
  • Relieves first symptoms such as hoarseness, dry cough, swollen lymph nodes and a sore throat and prevents worsening.
  • Reduces the duration of a sore throat/hoarseness.
  • The Ectoin® Hydro Complex and the stabilized mucosal barrier structure help to reduce bacterial, viral and allergen ingression based on preclinical data.

Ingredients

Mint: Ectoin®, Sea Salt, Phosphate Buffer, Mint Oil, Xylitol, Water.

Salvia: Ectoin®, Sea Salt, Phosphate Buffer, Mint Oil, Salvia Oil, Xylitol, Sodium Cyclamate, Caprylic Acid, Water.

Suitable for

Children older than two years, adolescents and adults.

Dosage Forms

20 ml bottle with dosage pump (3K)

 Study Overview

Müller et. al., 2016

  • Tested against mineral salt pastilles: proven superior efficacy in treating acute pharyngitis and/or laryngitis compared to Emser® Pastillen.

Status (EU): Medical Device Class IIa (under approval)


Ectoin® Soft Lozenges

Protection shield against common cold symptoms, dry mouth and hoarseness

Claims

Lozenges for treatment and prevention of common cold symptoms, dry mouth and throat, and hoarseness due to voice overuse.

  • Reduces inflammations of the mucous membranes in mouth, throat and larynx.
  • Relieves hoarseness, sore throat, or pain on swallowing.
  • Alleviates the urge to cough.
  • Reduces and prevents irritations of the mucous membranes such as voice fatigue, tickly throat, or dryness.
  • Relieve first symptoms such as hoarseness, dry cough and a sore throat and prevent worsening.
  • Forms a protective shield called “Ectoin® Hydro Complex” on mucous membranes in mouth and throat.
  • The Ectoin® Hydro Complex and the stabilized mucosal barrier structure helps to reduce bacterial, viral and allergen ingression.

Ingredients

Ectoin®, [Wildberry Flavour, Menthol, Grape Skin Extract] or [Honey Flavour, Lemon Oil, Lemon Yellow], Citric Acid, Acesulfame K, Gum Arabic, Maltitol, Sorbitol, Water, Vegetable Oil, Beeswax.

Suitable for

Children older than 6 years, adolescents and adults.

Dosage Forms

Blister strips containing 10 lozenges à 1 g or 2 g

 Study Overview

  • Tested against German bestseller (GeloRevoice®) and salt water gargling solution.
  • Significant improvement of sum of pharyngitis symptoms (pain on swallowing, tickle in the throat and hoarseness).

Status (EU): Medical Device Class IIa (under approval)


Ectoin® Hard Lozenges

Protection shield against common cold symptoms, dry mouth and hoarseness

Claims

Lozenges for treatment and prevention of common cold symptoms, dry mouth and throat, and hoarseness due to voice overuse.

  • Reduces inflammation of the mucous membranes in mouth and throat.
  • Relieves hoarseness, sore throat, or pain on swallowing.
  • Stabilizes the mucous membranes and thus reduces the danger of a bacterial or viral infection in mouth and throat.
  • Reduces and prevents irritations of the mucous membranes such as voice fatigue, tickly throat, or dryness.
  • Hydrates dry epithelia and supports their regeneration.

Ingredients

Honey Lemon: Ectoin®, Isomalt, Sucralose, Menthol, Citric Acid, Lemon Mint Flavour (containing tocopherol), Honey Flavour (containing polyethylene glycol), Safflor Concentrate, Glucose Syrup, Water.

Honey Salt: Ectoin®, Sea Salt, Isomalt, Sucralose, Honey Flavour (containing glycerol triacetate and propylene glycol), Safflower Concentrate, Glucose Syrup, Water.

Suitable for

Children older than 6 years, adolescents and adults.

Dosage Forms

Blister strips containing 8 lozenges à 2.3 g

 Study Overview

Studies with Ectoin® Lozenges show great efficacy in reducing sore throat and other pharyngitis symptoms.
 

Status (EU): Medical Device Class IIa (under approval)